pemafibrate
Kowa Pharmaceuticals
['cardio']
pemafibrate va placebo on top of ldl-lowering treatment in pts with high triglycerides and low hdl-cholesterol in diabetic pts. a debate as long as my career. despite 20-30% reduction in triglycerides, no impact on major cardiovascular events. #aha22 
Physician, epidemiologist & clinical trialist: https://t.co/PuSJzZsPC6 @oxford_ndph. Lead, Good Clinical Trials Collaborative https://t.co/Do4H97gzf0. CEO https://t.co/4YkPhZtWPG